2/28
01:00 pm
tmdx
Got $5,000? TransMedics Could Be a High-Tech Organ Transplant Moonshot [Yahoo! Finance]
Medium
Report
Got $5,000? TransMedics Could Be a High-Tech Organ Transplant Moonshot [Yahoo! Finance]
2/27
07:26 am
tmdx
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results [Yahoo! Finance]
Medium
Report
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results [Yahoo! Finance]
2/27
07:00 am
tmdx
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
Medium
Report
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
2/26
12:35 pm
tmdx
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? [Yahoo! Finance]
Low
Report
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? [Yahoo! Finance]
2/25
01:03 pm
tmdx
TransMedics Group, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
TransMedics Group, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/25
12:58 pm
tmdx
TransMedics Group (TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. They now have an "outperform" rating on the stock.
Low
Report
TransMedics Group (TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. They now have an "outperform" rating on the stock.
2/25
12:58 pm
tmdx
TransMedics Group (TMDX) had its price target raised by JPMorgan Chase & Co. from $114.00 to $149.00. They now have a "neutral" rating on the stock.
Low
Report
TransMedics Group (TMDX) had its price target raised by JPMorgan Chase & Co. from $114.00 to $149.00. They now have a "neutral" rating on the stock.
2/25
10:24 am
tmdx
TransMedics Group (TMDX) had its price target raised by Piper Sandler from $140.00 to $160.00. They now have an "overweight" rating on the stock.
Medium
Report
TransMedics Group (TMDX) had its price target raised by Piper Sandler from $140.00 to $160.00. They now have an "overweight" rating on the stock.
2/25
08:03 am
tmdx
TransMedics Group (TMDX) had its price target raised by Needham & Company LLC from $166.00 to $174.00. They now have a "buy" rating on the stock.
High
Report
TransMedics Group (TMDX) had its price target raised by Needham & Company LLC from $166.00 to $174.00. They now have a "buy" rating on the stock.
2/25
12:27 am
tmdx
TransMedics Group Inc (TMDX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
High
Report
TransMedics Group Inc (TMDX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
2/24
04:05 pm
tmdx
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
2/20
04:05 pm
tmdx
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2/17
04:05 pm
tmdx
TransMedics to Present at Upcoming March Investor Conferences
Low
Report
TransMedics to Present at Upcoming March Investor Conferences
2/14
01:32 am
tmdx
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at
Wall Street
Medium
Report
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at
Wall Street
2/10
04:05 pm
tmdx
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Medium
Report
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
2/9
08:00 am
tmdx
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
Low
Report
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
2/3
09:43 pm
tmdx
TransMedics Group, Inc. (TMDX): A Bull Case Theory [Yahoo! Finance]
Medium
Report
TransMedics Group, Inc. (TMDX): A Bull Case Theory [Yahoo! Finance]
2/3
07:20 am
tmdx
TransMedics: Italian NOP Program Reinforces Huge International Opportunity [Seeking Alpha]
Low
Report
TransMedics: Italian NOP Program Reinforces Huge International Opportunity [Seeking Alpha]
1/31
01:33 am
tmdx
TransMedics Group (NASDAQ:TMDX) was downgraded by analysts at
Wall Stree
Low
Report
TransMedics Group (NASDAQ:TMDX) was downgraded by analysts at
Wall Stree
1/12
08:10 am
tmdx
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
Low
Report
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
1/8
07:11 am
tmdx
Is Now The Time To Put TransMedics Group (NASDAQ:TMDX) On Your Watchlist? [Yahoo! Finance]
Low
Report
Is Now The Time To Put TransMedics Group (NASDAQ:TMDX) On Your Watchlist? [Yahoo! Finance]
12/30
04:10 pm
tmdx
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/30
04:05 pm
tmdx
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/28
01:08 am
tmdx
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at
Wall Street
Low
Report
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at
Wall Street
12/24
04:05 pm
tmdx
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)